Patient Guide: A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 17 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07154290
Status: 🟢 Enrolling Now
Condition: Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung
Phase: Phase II

Find a Study Location Near You

This study is available at 17 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Birmingham, Alabama
  • • Goodyear, Arizona
  • • Irvine, California
  • • And 14 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) - Join Clinical Trial NCTNCT07154290

How to Join This Clinical Trial - NCTNCT07154290

Learn how to participate in this Phase II trial studying an investigational therapy for Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
Phase II - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07154290 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 17 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35233 - United States

Status: RECRUITING

Clinical Research Site

Goodyear, Arizona 85338 - United States

Status: RECRUITING

Clinical Research Site

Irvine, California 92618 - United States

Status: RECRUITING

Clinical Research Site

Newark, Delaware 19713 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20007 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: RECRUITING

Clinical Research Site

Munster, Indiana 46321 - United States

Status: RECRUITING

Clinical Research Site

Baltimore, Maryland 21201 - United States

Status: RECRUITING

And 7 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase II clinical trial for Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer, Carcinoma Non Small Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation